This suggests that UI is an important factor in the lives and health of Medicare beneficiaries whether or not they have been diagnosed with cancer.
This study attempted to address this limitation by capturing proxies for motivation (e.g., whether the household applied for government programs including Bolsa Família), social networks (e.g., whether the respondent knew any Bolsa Família beneficiaries, whether respondent belonged to a group), and other typically unobserved characteristics in the detailed questionnaire.
As my colleague Michael Schulman has written, the allegations of sexual harassment and related lawsuits that Affleck has faced may stay the hand of some voters; if that's so, the question is whether Washington will be the beneficiary or whether, in an altogether frothier register, Ryan Gosling, in "La La Land," will squeeze through.
Special attention should be paid to eligibility, targeting, and profiling mechanisms; selection of businesses to be supported; adaptation of core interventions (training, access to finance, advisory and mentoring services, and networking) to beneficiary needs; whether and how programs are integrated into subsectors and/or value chains; and delivery mechanisms for different services.
Few tax credit beneficiaries know whether they are getting too little or too much.
The judge, Henry H. Kennedy Jr. of Federal District Court here, said the Medicare law required the government to provide such data to help beneficiaries decide whether to enroll in a particular health maintenance organization.
A case study in Chhattisgarh state in India has been carried out to assess what effect village electrification through solar power has had for the beneficiaries and whether technical and maintenance factors provide for the desired results set by Indian rural electrification policy.
We categorized beneficiaries into whether they filled only one prescription for an opioid or filled two or more prescriptions from one unique provider or two, three, or four or more providers.
Additionally, the impact of the modestly increased adherence observed in the present study on long-term clinical outcomes is not well understood, and the financial burden associated with higher costs among non-LIS beneficiaries and whether they lead to unacceptable tradeoffs for this group is unknown.
Primary explanatory variables of interest included indicator variables for whether beneficiary received opioid prescriptions from 1, 2, 3, or ≥4 providers.
